ACAM2000
ACAM2000 (pronunciation: A-CAM-Two-Thousand) is a vaccine used to protect against smallpox, a highly contagious and deadly disease caused by the variola virus.
Etymology
The term "ACAM2000" is derived from the name of the company that developed the vaccine, Acambis, and the year 2000, which signifies the period when the development of the vaccine was completed.
Description
ACAM2000 is a live, vaccinia virus-based vaccine. It is derived from the same strain (New York City Board of Health strain) as Dryvax, the previous smallpox vaccine, but is grown in cell culture rather than on the skin of calves.
Usage
ACAM2000 is used to protect people who are at high risk of smallpox infection. It is also used to boost protection in people who have been vaccinated before. The vaccine is administered using a bifurcated (two-pronged) needle that is dipped into the vaccine solution. The needle is used to prick the skin (usually the upper arm) multiple times in a few seconds.
Side Effects
Like all vaccines, ACAM2000 can cause side effects. The most common side effects are mild and include fever, rash, and headache. Serious side effects are rare, but can include heart inflammation and other heart problems.
Related Terms
External links
- Medical encyclopedia article on ACAM2000
- Wikipedia's article - ACAM2000
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski